All analyses
AI analysis

Singer Finance (Lanka) Plc: research report

UndervaluedbullishNov 16, 2026

Evidence points bullish: lending income and profit continued to grow, while the completed rights issue adds capital for lending. The catch is that liabilities were 9.0 times equity.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • September-quarter revenue rose 38.4% year-on-year and net profit rose 15.9%, showing growth continued despite lower margins.
  • The 76.6 million-share rights issue at LKR 39.20 provides about LKR 3.0 billion for capital adequacy and lending.
  • The shares score 82 of 100 for value against book value, earnings and dividends across the CSE.

Against this. Operating margin narrowed to 38.6% from 45.0%, while liabilities stood at 9.04 times equity.

Operating margin
38.6%sector 39.5%
from 45.0% a year earlier
Net margin
16.5%sector 16.3%
from 19.7% a year earlier, revenue +38.4%
Return on equity
17.5%
twelve months to Sep 30, 2026, unaudited
P/E
6.8sector 7.1
earnings Rs 6.49 per share, year to Sep 2026
P/B
1.19sector 0.97
book Rs 37.04 per share
Dividend yield
2.25%sector 0.75%
15.2% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 16, 2026. Sector figures are the median of 54 listed companies in the same sector.

Overview

Singer Finance is a non-bank lender focused on lending, leasing, deposits and vehicle finance through branches and digital channels. The central change is rapid balance-sheet and income growth, with lending capacity reinforced by a completed rights issue, but recent profitability has not kept pace with revenue growth.

Price performance

At LKR 43.00 on 16 November 2026, the share had fallen 12.9% over three months while the ASPI gained 0.5%, and it was down 37.8% over one year against a 6.9% ASPI fall. The price sat 17.2% up from its 52-week low, so it remained near the lower end of its own annual range.

The record is four falls of 15% or more in three years, the deepest 51%, which has not yet recovered. Liquidity is limited: median daily turnover was LKR 811,448 over 60 sessions, and a LKR 1 million order is more than everything that trades on a typical day (123% of it).

Valuation

The valuation band is Undervalued, with a score of 82 of 100 across price against book value, earnings and dividends. At 6.7 times P/E, the market pays LKR 6.70 for each LKR 1 of trailing profit, modestly below the finance-sector median of 7.1 times. P/B is 1.16 times, meaning LKR 1.16 for each LKR 1 of net assets, above the sector median of 0.93 times; the trailing ROE of 17.5% helps explain why the shares trade above book.

The company’s own year-end record is less cheap than the sector comparison: P/E was more expensive than at 8 of the last 15 year-ends and P/B more expensive than at 11. A buyer at this price relies on the latest quarter for 25.3% of trailing EPS; its 16.5% net margin was below the year-ago 19.7%, although the same price would be 6.4 times earnings if that quarter had matched the earlier margin. The 2.3% dividend yield is below the sector median of 3.5%; the latest recorded DPS is LKR 0.988, versus LKR 1.32 in FY2022, but the latest year may be incomplete.

News and sentiment

Direct coverage was normal rather than unusually loud, with 11 material articles in the last 90 days, including three positive and no negative items. The main corporate development was the rights issue declared on 19 August 2026 and completed with an ex-date of 16 October: shares were offered at LKR 39.20 on an 8:29 ratio, a 5.8% discount to the pre-ex market price, to support capital adequacy and lending.

Board changes were also reported, including Jonathan Alles becoming chairman effective 12 September 2026 and the Central Bank-approved appointment of Geethaka Fernando to the board.

Financials

September-quarter revenue grew 38.4% year-on-year to LKR 2.8 billion, but operating profit grew a slower 18.6% and net profit 15.9% to LKR 464 million. Gross margin is not available in the supplied lender presentation. Operating margin narrowed from 45.0% to 38.6%, while net margin declined from 19.7% to 16.5%; both were middling against the company’s past September quarters, ranking third of seven and fourth of seven respectively. The business earned less on each rupee of revenue than a year earlier, even as absolute profit grew.

Below-the-line items absorbed LKR 620 million, up from LKR 514 million a year earlier, explaining why net profit lagged operating profit. Over the twelve months to 30 September 2026, revenue rose 45.9% and ROE was 17.5%, indicating strong growth in the earnings generated on shareholders’ capital.

Equity rose to LKR 10.3 billion from LKR 6.8 billion a year earlier. The September filing used 277.9 million shares, compared with 202.1 million a year earlier, so EPS comparisons across the periods are affected by the larger share base and absolute profit is the clearer performance measure.

Risks

The principal balance-sheet risk is lender leverage: total liabilities were 9.04 times equity at March 2026, up from 8.36 times a year earlier. Deposits and borrowings are integral to a finance company’s model, but this level means changes in funding conditions or loan performance have a large effect on the capital base.

Profitability is the next risk. September operating margin fell 6.4 percentage points year-on-year, while below-the-line costs increased, so revenue growth did not translate fully into profit growth. Sector context also warrants attention: banking-sector lending was outpacing deposits, with the credit-to-deposit ratio at 74.0% at end-June, and the Central Bank warned of system-wide risk from the shift toward private lending.

Outlook

As at 16 November 2026, the next defined event is the interim filing for the quarter ending 31 December 2026, expected between 6 and 14 February 2027. It should show whether the added rights capital is being deployed into lending while preserving margins, or whether the margin compression seen in September persists.

The data cannot establish loan quality, funding mix or capital adequacy ratios. The next filing is therefore the first scheduled evidence on how the larger capital base is affecting the operating business.

About this report. Generated on Nov 16, 2026 from market data up to Nov 16, 2026, 11 material news articles over 90 days and financials to Sep 30, 2026, and scored 82 of 100 on value (undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports